TY - JOUR
T1 - The potential of nano-enabled oral ecosystem surveillance for respiratory disease management
AU - Shi, Yuhong
AU - Chen, Lin
AU - Zhang, Hao
AU - Nie, Guangjun
AU - Zhang, Zhijian
AU - Zhu, Motao
N1 - Funding Information:
This work was supported by the National Basic Research Plan of China ( 2021YFA1201100 , 2018YFA0208900 ), the Strategic Priority Research Program of Chinese Academy of Sciences ( XDB36000000 ), and the National Center for Nanoscience and Technology of China ( E1773911 ). The figures (except adapted from the published figures) were created with BioRender.com.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2023/2
Y1 - 2023/2
N2 - The association between oral disorders and respiratory diseases has been revealed for decades. Emerging oral biomarkers, including microbiome, metabolites, proteins, and nucleic acids, have been gradually discovered and proposed to contribute to the development and progression of both oral and respiratory diseases. While promising, oral ecosystem surveillance remains confined due to the constant changes in the oral ecosystem and the lack of sophisticated assessment technologies. With the advent of nanotechnology, efficient diagnostics and real-time monitoring of disease are implemented via platforms such as biomarker-capturing nanoparticles, nanobiosensors, nano-microfluidics, and wearable devices. In this review, the association between the oral ecosystem and respiratory system, especially the clinical relevance and cross-regulatory mechanisms, will be first discussed. Saliva, serving as a readily available biofluid for non-invasive diagnostics, will be overviewed for the emerging biomarkers in respiratory disease diagnosis. The latest nanotechnology-enabled approaches will be highlighted in terms of oral biomarker enrichment, multiplexing analysis, sensitive and selective diagnosis, and nanodentistry. Finally, the incorporation of nano-enabled approaches into routine clinical practice will be prospected for future translation.
AB - The association between oral disorders and respiratory diseases has been revealed for decades. Emerging oral biomarkers, including microbiome, metabolites, proteins, and nucleic acids, have been gradually discovered and proposed to contribute to the development and progression of both oral and respiratory diseases. While promising, oral ecosystem surveillance remains confined due to the constant changes in the oral ecosystem and the lack of sophisticated assessment technologies. With the advent of nanotechnology, efficient diagnostics and real-time monitoring of disease are implemented via platforms such as biomarker-capturing nanoparticles, nanobiosensors, nano-microfluidics, and wearable devices. In this review, the association between the oral ecosystem and respiratory system, especially the clinical relevance and cross-regulatory mechanisms, will be first discussed. Saliva, serving as a readily available biofluid for non-invasive diagnostics, will be overviewed for the emerging biomarkers in respiratory disease diagnosis. The latest nanotechnology-enabled approaches will be highlighted in terms of oral biomarker enrichment, multiplexing analysis, sensitive and selective diagnosis, and nanodentistry. Finally, the incorporation of nano-enabled approaches into routine clinical practice will be prospected for future translation.
KW - Nanobiosensors
KW - Nanodentistry
KW - Oral ecosystem
KW - Respiratory disease diagnosis
KW - Salivary biomarkers
UR - http://www.scopus.com/inward/record.url?scp=85142331833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142331833&partnerID=8YFLogxK
U2 - 10.1016/j.nantod.2022.101693
DO - 10.1016/j.nantod.2022.101693
M3 - Review article
AN - SCOPUS:85142331833
SN - 1748-0132
VL - 48
JO - Nano Today
JF - Nano Today
M1 - 101693
ER -